LM-41, a Flufenamic acid-derived TEAD inhibitor, significantly reduces the expression of CTGF, Cyr61, Axl, and NF2, and inhibits the migration of human MDA-MB-231 breast cancer cells [1].
Molecular Weight:
307.32
Formula:
C19H14FNO2
Target:
YAP
* VAT and and shipping costs not included. Errors and price changes excepted
